Welbe Beheer

Beheer criteriumcontroles 2/4

De CEO Welbe is Makoto Ota, benoemd in Dec2011, heeft een ambtstermijn van 12.5 jaar. bezit rechtstreeks 20% van de aandelen van het bedrijf, ter waarde ¥ 5.98B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8 jaar en 5 jaar.

Belangrijke informatie

Makoto Ota

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	12.5yrs
Eigendom CEO	20.0%
Management gemiddelde ambtstermijn	8yrs
Gemiddelde ambtstermijn bestuur	5yrs

Recente managementupdates

Recent updates

Why Investors Shouldn't Be Surprised By Welbe, Inc.'s (TSE:6556) 28% Share Price Surge

Feb 26

CEO

Makoto Ota (52 yo)

12.5yrs

Tenure

Mr. Makoto Ota serves as President and Representative Director at Welbe, Inc. since December 2011. Mr. Ota served as Director & Vice President; General Manager of Administration Division; Manager of Medica...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Makoto Ota	President & Representative Director	12.5yrs	geen gegevens	20% ¥ 6.0b
Hideyuki Nakazato	GM of Welfare Service Business Department & Director	8.6yrs	geen gegevens	0% ¥ 0
Takao Senga	Senior EVP	8yrs	geen gegevens	0% ¥ 0
Koichi Ito	Director & GM of Business Planning Department	4.2yrs	geen gegevens	0% ¥ 0
Takuo Touma	Director & GM of Employment Transition Support Department	2.8yrs	geen gegevens	geen gegevens

8.0yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 6556 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Makoto Ota	President & Representative Director	12.5yrs	geen gegevens	20% ¥ 6.0b
Hideyuki Nakazato	GM of Welfare Service Business Department & Director	8yrs	geen gegevens	0% ¥ 0
Takao Senga	Senior EVP	8yrs	geen gegevens	0% ¥ 0
Koichi Ito	Director & GM of Business Planning Department	5yrs	geen gegevens	0% ¥ 0
Takuo Touma	Director & GM of Employment Transition Support Department	2yrs	geen gegevens	geen gegevens
Yasutoshi Kita	Independent Outside Director	8yrs	geen gegevens	0% ¥ 0
Hiyoshi Sato	Outside Independent Director	3yrs	geen gegevens	0% ¥ 0
Shigenobu Kanba	External Independent Outside Director	5yrs	geen gegevens	geen gegevens
Eri Watanabe	Director	no data	geen gegevens	0% ¥ 0
Yumiko Noguchi	External Independent Outside Director	2yrs	geen gegevens	geen gegevens

5.0yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 6556 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).

Welbe Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Welbe, Inc., Annual General Meeting, Jun 28, 2022

Less than half of directors are independent

Recent updates

Welbe, Inc. to Delist from Prime Section of Tokyo Stock Exchange, Effective June 11, 2024

Welbe, Inc. to Delist from Prime Section of Tokyo Stock Exchange, Effective June 11, 2024

Full year 2024 earnings released: EPS: JP¥44.12 (vs JP¥48.69 loss in FY 2023)

Welbe, Inc. to Report Fiscal Year 2024 Results on May 14, 2024

Why Investors Shouldn't Be Surprised By Welbe, Inc.'s (TSE:6556) 28% Share Price Surge

Third quarter 2024 earnings released: EPS: JP¥11.72 (vs JP¥2.90 in 3Q 2023)

New major risk - Revenue and earnings growth

Welbe, Inc. to Report Q3, 2024 Results on Feb 13, 2024

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: JP¥11.65 (vs JP¥14.77 in 2Q 2023)

New major risk - Share price stability

Now 22% undervalued

Welbe, Inc. to Report Q2, 2024 Results on Nov 13, 2023

Welbe, Inc. Provides Consolidated Financial Forecast for the First Half of 2024 and Fiscal Year Ending March 31, 2024

First quarter 2024 earnings released: EPS: JP¥8.06 (vs JP¥55.02 loss in 1Q 2023)

Now 20% undervalued after recent price drop

Welbe, Inc. to Report Q1, 2024 Results on Aug 10, 2023

Welbe, Inc Provides Dividend Guidance for the Second Quarter Ending September 30, 2023 and Year Ending March 31, 2024

Third quarter 2023 earnings released: EPS: JP¥2.90 (vs JP¥18.13 in 3Q 2022)

Welbe, Inc. to Report Q3, 2023 Results on Feb 13, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥14.77 (vs JP¥16.36 in 2Q 2022)

WH LLC agreed to acquire Welbe Healthcare Inc from Welbe, Inc. (TSE:6556) for ¥ approximately 1.8 billion.

Welbe, Inc. to Report Q2, 2023 Results on Nov 11, 2022

Welbe, Inc. Provides Dividend Guidance for the Full Year Ending March 31, 2023

Welbe, Inc. (TSE:6556) announces an Equity Buyback for 1,550,000 shares, representing 5.38% for ¥1,000 million.

First quarter 2023 earnings released: JP¥55.02 loss per share (vs JP¥13.91 profit in 1Q 2022)

Welbe, Inc. Ordinary Shares to Be Deleted from OTC Equity

Consensus forecasts updated

Welbe, Inc., Annual General Meeting, Jun 28, 2022

Price target decreased to JP¥1,500

Less than half of directors are independent

Welbe, Inc. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥8.10 per share

Investor sentiment deteriorated over the past week

Welbe, Inc. Provides Earnings Guidance for the Year Ending March 31, 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to JP¥1,950

Second quarter 2022 earnings released: EPS JP¥16.36 (vs JP¥11.95 in 2Q 2021)

Upcoming dividend of JP¥8.00 per share

Investor sentiment improved over the past week

Upcoming dividend of JP¥10.30 per share

Welbe, Inc. to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: JP¥1,464

Welbe, Inc. to Report Q2, 2021 Results on Nov 13, 2020

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd